ARDT Stock Analysis: Buy, Sell, or Hold?
ARDT - Ardent Health, Inc.
$10.99
0.51 (4.87%)
â˛
5d:
+0.73%
30d:
+5.47%
90d:
+19.33%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When ARDT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ARDT is fairly priced but lacks strong directional signals. At 6.9% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ARDT is fairly priced but lacks strong directional signals. At 6.9% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$13.42
Based on 8.5% avg growth
INTRINSIC VALUE TODAY
$8.33
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARDT is currently trading at $10.99, which is considered slightly high relative to its 30-day fair value range of $10.38 to $11.19. From a valuation perspective, the stock is trading at a premium (Forward PE: 8.9) compared to its historical average (7.3). At these levels, the market is pricing in 6.9% annual earnings growth.
Technical Outlook: Technically, ARDT is in a uptrend. Immediate support is located at $10.35, while resistance sits at $11.72. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: ARDT scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.68 (+15.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARDT is in a uptrend. Immediate support is located at $10.35, while resistance sits at $11.72. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: ARDT scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.68 (+15.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$10.38 -
$11.19
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
48.6%
All Signals
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.9%)
- BULLISH: Trading below Wall St target ($12.68)
- BULLISH: Expecting earnings turnaround to 6.9% growth with -1.4% revenue growth
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$10.38 -
$11.19
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$10.35
Resistance Level
$11.73
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.95
Wall Street Target
$12.68
(+15.4%)
Revenue Growth (YoY)
-1.4%
Earnings Growth (YoY)
-77.1%
Profit Margin
1.2%
Valuation Premium vs History
+6.9% premium
PE vs Historical
9.0 vs 7.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.9%
(market-implied from PE analysis)
1-Year Target
$11.75
(+7%)
2-Year Target
$12.56
(+14%)
3-Year Target
$13.43
(+22%)
3-Yr Target (if PE normalizes)
(PE: 9â7)
PE COMPRESSION
$10.95
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 12.9%)
$35.49
(+223%)
Base:
(SPY PE: 8.9, Growth: 12.9%)
$15.82
(+44%)
Bear:
(PE: 7.3, Growth: 12.9%)
$12.91
(+17%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 19.41 | Current EPS (TTM): $0.54
Bull Case
$23.06
(+110%)
Analyst growth 100.0%, PE expands to 21.4
Base Case
$20.96
(+91%)
Market implied 100.0%, PE stable at 19.4
Bear Case
$7.13
(-35%)
Severe decline -20.0%, PE contracts to 16.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 23, 2026 1:03 AM ET
Data refreshes hourly during market hours. Next update: 2:03 AM
Data refreshes hourly during market hours. Next update: 2:03 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARDT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare CorporaâĻ |
STRONG BUY
22 analysts |
$282 | 37 SELL |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$455 | 44 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 42 HOLD |
|
ADUS
Addus HomeCare CorporatiâĻ |
STRONG BUY
11 analysts |
$135 | 54 HOLD |